NanoString Technologies, Inc. (NASDAQ: NSTG) director Kirk Malloy sold 3,000 shares of the company in a trade on Monday, September 13. The shares were sold at an average price of $ 59.37, for a total trade of $ 178,110.00. The sale was disclosed in a document filed with the SEC, available at the SEC website.
Kirk Malloy also recently completed the following transactions:
- On Monday August 16, Kirk Malloy sold 1,500 shares of NanoString Technologies. The shares were sold at an average price of $ 55.82, for a total trade of $ 83,730.00.
- On Tuesday, July 13, Kirk Malloy sold 1,500 shares of NanoString Technologies. The shares were sold at an average price of $ 61.16, for a total trade of $ 91,740.00.
Actions of NASDAQ: NSTG traded at $ 0.20 on Wednesday, reaching $ 55.75. 290,364 shares of the company were traded, for an average volume of 524,128. The company has a fifty-day moving average of $ 58.63 and a 200-day moving average of $ 62.06. NanoString Technologies, Inc. has a twelve month low of $ 34.31 and a twelve month high of $ 86.42. The company has a market cap of $ 2.54 billion, a price-to-earnings ratio of -24.07 and a beta of 1.70. The company has a current ratio of 10.81, a rapid ratio of 10.14 and a debt ratio of 1.02.
NanoString Technologies (NASDAQ: NSTG) last reported its results on Wednesday, August 4. The biotech company reported ($ 0.60) earnings per share (EPS) for the quarter, missing Zacks’ consensus estimate of ($ 0.56) ($ 0.04). The company posted revenue of $ 33.86 million for the quarter, compared to analysts’ estimates of $ 32.30 million. NanoString Technologies recorded a negative return on equity of 45.77% and a negative net margin of 74.15%. The company’s revenue grew 49.8% year-over-year. As a group, equity research analysts predict that NanoString Technologies, Inc. will post EPS of -2.19 for the current fiscal year.
Separately, Zacks investment research raised NanoString Technologies shares from a âsellâ rating to a âconservationâ rating in a research note on Saturday. Two investment analysts gave the stock a conservation rating and three gave the stock a buy rating. According to MarketBeat, the stock currently has a consensus rating of âBuyâ and an average price target of $ 76.20.
Several hedge funds and other institutional investors have recently bought and sold stocks. Dark Forest Capital Management LP acquired a new stake in NanoString Technologies in the second quarter valued at approximately $ 40,000. Maverick Capital Ltd. increased its stake in NanoString Technologies shares by 425.7% during the second quarter. Maverick Capital Ltd. now owns 1,656 shares of the biotech company valued at $ 107,000 after acquiring 1,341 additional shares in the last quarter. Shell Asset Management Co. purchased a new position in shares of NanoString Technologies during the first quarter valued at $ 190,000. Advisor Group Holdings Inc. increased its stake in NanoString Technologies shares by 25.6% during the second quarter. Advisor Group Holdings Inc. now owns 3,211 shares of the biotech company valued at $ 208,000 after acquiring 654 additional shares in the last quarter. Finally, Russell Investments Group Ltd. purchased a new position in shares of NanoString Technologies during the first quarter valued at $ 216,000.
NanoString Technologies Company Profile
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for the profiling of genes and proteins from tissue samples. It offers the GeoMx Digital Spatial Profiler and nCounter Analysis System product platforms, both of which include instruments, associated consumables, and software.
Further Reading: How Does the Federal Reserve Determine Interest Rates?
This instant news alert was powered by narrative science technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [emailÂ protected]
Should you invest $ 1,000 in NanoString technologies now?
Before you consider NanoString Technologies, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold ofâ¦ and NanoString Technologies was not on the list.
While NanoString Technologies currently has a âBuyâ rating among analysts, top-rated analysts believe these five stocks are better bets.
See the 5 actions here